Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma

International Journal of Hygiene and Environmental Health

Volumn 212, Issue 3, 2009, Pages 322-329

  Betti, Marta ^a   Neri, Monica ^b   Ferrante, Daniela ^a   Landi, Stefano ^c   Biava, Alessandra ^a   Gemignani, Federica ^c   Bertolotti, Marinella ^a   Mirabelli, Dario ^d   Padoan, Marina ^a   Ugolini, Donatella ^b,e   Botta, Mario ^f   Bonassi, Stefano ^b   Magnani, Corrado ^a   Dianzani, Irma ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f Unit of Medical Oncology   (Italy)

Author keywords

Asbestos; Mesothelioma; N acetyltransferase; Oxidative stress; Single nucleotide polymorphism

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ASBESTOS; CARCINOGEN; NAT2 PROTEIN, HUMAN;

ACETYLATION; AGED; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FACTUAL DATABASE; FEMALE; FINLAND; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; ITALY; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PHENOTYPE; PLEURA TUMOR; RISK; STATISTICAL MODEL;

ACETYLATION; AGED; ARYLAMINE N-ACETYLTRANSFERASE; ASBESTOS; CARCINOGENS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; ODDS RATIO; PHENOTYPE; PLEURAL NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 62649155913     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2008.08.001     Document Type: Article

References (43)

1. Ascoli V., Scalzo C.C., Bruno C., Facciolo F., Lopergolo M., Granone P., and Nardi F. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett. 130 (1998) 203-207
2. Ascoli V., Cavone D., Merler E., Barbieri P.G., Romeo L., Nardi F., and Musti M. Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy case sane review of the literature. Am. J. Ind. Med. 50 (2007) 357-369
3. Bianchi C., Giarelli L., Grandi G., Brollo A., Ramani L., and Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur. J. Cancer Prev. 6 (1997) 162-166
4. Chen Q., Marsh J., Ames B., and Mossman B.T. Detection of 8-oxo-2′-deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos. Carcinogenesis 17 (1996) 2525-2527
5. Christensen B.C., Godleski J.J., Marsit C.J., Houseman E.A., Lopez-Fagundo C.Y., Longacker J.L., Bueno R., Sugarbaker D.J., Nelson H.H., and Kelsey K.T. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis (2008) (2008 February 28. [Epub ahead of print])
6. Dianzani I., Gibello L., Biava A., Giordano M., Bertolotti M., Betti M., Ferrante D., Guarrera S., Betta G.P., Mirabelli D., Matullo G., and Magnani C. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res. 599 (2006) 124-134
7. Fung H., Kow Y.W., Van Houten B., and Mossman B.T. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 18 (1997) 825-832
8. Gemignani F., Landi S., Vivant F., Zienolddiny S., Brennan P., and Canzian F. A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility. Pharmacogenetics 12 (2002) 459-463
9. Gennaro V., Ugolini D., Viarengo P., Benfatto L., Bianchelli M., Lazzaretto A., Montanaro F., and Puntoni R. Incidence of pleural mesothelioma in Liguria Region, Italy (1996-2002). Eur. J. Cancer 41 (2005) 2709-2714
10. Guo Z., Guilfoyle R.A., Thiel A.J., Wang R., and Smith L.M. Direct fluorescence analysis of genetic polymorphisms by hibridization with oligonucleotide arrays on glass supports. Nucleic Acids Res. 22 (1994) 5456-5465
11. Hein D.W. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 506-507 (2002) 65-77
12. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb Xiao G.H., Devanaboyina U.S., Nangju N.A., and Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 29-42
13. Hein D.W., Grant D.M., and Sim E. Update on consensus N-acetyltransferase gene nomenclature. Pharmacogenetics 10 (2000) 291-292
14. Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., and Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res. 55 (1995) 2981-2983
15. Hirvonen A., Saarikoski S.T., Linnaunmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., and Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst. 88 (1996) 1853-1856
16. Jensen C.G., Jensen L.C.W., Rieder C.L., Cole R.W., and Ault J.C. Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis 17 (1996) 2013-2021
17. Landi S., Gemignani F., Gioia-Patricola L., Chabrier A., and Canzian F. Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair. Biotechniques 35 (2003) 816-820 822, 824-827
18. Landi S., Gemignani F., Monnier S., and Canzian F. A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer. Exp. Lung Res. 31 (2005) 223-258
19. Landi S., Gemignani F., Neri M., Barale R., Bonassi S., Bottari F., Vanessa P.A., Canzian F., Ceppi M., Filiberti R., Ivaldi G.P., Mencoboni M., Scaruffi P., Tonini G.P., Mutti L., and Puntoni R. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int. J. Cancer 120 (2007) 2739-2743
20. Lee W.C., and Testa J.R. Somatic genetic alterations in human malignant mesothelioma. Int. J. Oncol. 14 (1999) 181-188
21. Magnani C., Agudo A., Gonzales C.A., Andrion A., Calleja A., Chellini E., Dalmasso P., Escolar A., Hernandez S., Ivaldi C., Mirabelli D., Ramirez J., Turuguet D., Usel M., and Terracini B. Multicentric study on malignant mesothelioma and non-occupational exposure to asbestos. Br. J. Cancer 83 (2000) 104-111
22. Magnani C., Dalmasso P., Biggeri A., Ivaldi C., Mirabelli D., and Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos. A case-control study in Casale Monferrato-Italy. Env. Health Persp. 109 (2001) 915-919
23. Magnani C., Ferrante D., Barone Adesi F., Bertolotti M., Todesco A., Mirabelli D., and Terracini B. Cancer risk after cessation of asbestos exposure. A cohort study of Italian asbestos cement workers. Occup. Environ. Med. (2007) 1-17
24. Manning C.B., Cummins A.B., Jung M.W., Berlanger I., Timblin C.R., Palmer C., Taatjes D.J., Hemenway D., Vacek P., and Mossman B.T. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression. Cancer Res. 62 (2002) 4169-4175
25. Marsh J.P., and Mossman B.T. Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells. Cancer Res. 51 (1991) 167-173
26. Metspalu A., and Shumaker J.M. DNA resequencing mutation detection and gene expression analysis by oligonucleotide microchips. Biomethods 10 (1999) 371-397
27. Neri M., Filiberti R., Taioli E., Garte S., Paracchini V., Bolognesi C., Canessa P.A., Fontana V., Ivaldi G.P., Verna A., Bonassi S., and Puntoni R. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat. Res. 592 (2005) 36-44
28. Neri M., Taioli E., Filiberti R., Ivaldi G.P., Canessa P.A., Verna A., Marroni P., Puntoni R., Hirvonen A., and Garte S. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finish and Italian populations. Int. J. Hyg. Environ.-Health 209 (2006) 393-398
29. Neri M., Ugolini D., Dianzani I., Gemignani F., Landi S., Cesario A., Magnani C., Mutti L., Puntoni R., and Bonassi S. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat. Res. 659 (2008) 126-136
30. Robinson B.W., Musk A.W., and Lake R.A. Malignant mesothelioma. Lancet 366 (2005) 397-408
31. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
32. Roushdy-Hammady I., Siegel J., Emri S., Testa J.R., and Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357 (2001) 444-445
33. Sanderson S., Salanti G., and Higgins J. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. Am. J. Epidemiol. 166 (2007) 741-751
34. Seiler N., and Bolkenius F.N. Polyamine reutilization and turnover in brain. Neurochem. Res. 10 (1985) 529-544
35. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 73 (2003) 1162-1169
36. Tõnisson N., Zernant J., Kurg A., Pavel H., Slavin G., Roomere H., Meiel A., Hainaut P., and Metspalu A. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc. Natl. Acad. Sci. USA 99 (2002) 5503-5508
37. Ugolini D., Neri M., Ceppi M., Cesario A., Dianzani I., Filiberti R., Gemignani F., Landi S., Magnani C., Mutti L., Puntoni R., and Bonassi S. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat. Res. 658 (2008) 162-171
38. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181-182 (2002) 457-462
39. Wang D., Kreutzer D.A., and Essigmann J.M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 400 (1998) 99-115
40. Wang H., Vath G.M., Kawamura A., Bates C.A., Sim E., Hanna P.E., and Wagner C.R. Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1. Protein J. 24 (2005) 65-77
41. Wikman H., Thiel S., Jager B., Schmezer P., Spiegelhalder B., Edler L., Dienemann H., Kayser K., Schulz V., Drings P., Bartsch H., and Risch A. A relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics 11 (2001) 157-168
42. Yang H., Bocchetta M., Kroczynska B., Elmishad A.G., Chen Y., Liu Z., Bubici C., Mossman B.T., Pass H.I., Testa J.R., Franzoso G., and Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc. Natl. Acad. Sci. USA 103 27 (2006) 10397-10402
43. Zanella C.L., Posada J., Tritton T.R., and Mossman B.T. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res. 56 (1996) 5334-5338